Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation
- Conditions
- Premature Ejaculation
- Interventions
- Device: Functional TENS stimulationDevice: Non-Functional TENS stimulation
- Registration Number
- NCT03177226
- Lead Sponsor
- Virility Medical Ltd.
- Brief Summary
Prospective, non-randomized, controlled, single-center study, to evaluate the efficacy of applied nominal electrical stimulation parameters given to premature ejaculation (PE) patients in order to prolong the ejaculatory latency time which will eventually increase the quality of their sexual life.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- 30
- Good general health
- Clinical history of premature ejaculation
- Familiar with self- stimulation
- Ability to follow study instructions and complete study assessment tools
- Washout period of two weeks
- History of cardio-vascular disorders
- Any type of implanted pacemaker/defibrillator
- Hypertension
- Diabetes Mellitus
- Local dermatological disease
- Local skin irritation/ lesions
- Any neurological disorder
- Any psychiatric disease and/or any psychiatric medications
- Any neoplastic disease in the past two years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Functional TENS stimulation Functional TENS stimulation Short stimulation to identifying Sensory Threshold and Motor Threshold, followed by continuous functional electrical stimulation, throughout the entire self-stimulation phase \[from full erection to ejaculation\] Non-stimulation treatment Non-Functional TENS stimulation Short stimulation to identifying Sensory Threshold and Motor Threshold, followed by continuous non-functional electrical stimulation, throughout the entire self-stimulation phase \[from full erection to ejaculation\]
- Primary Outcome Measures
Name Time Method Incidence of Treatment-Emergent Adverse Events Procedure day All Self reported safety events (e.g. discomfort, pain, local irritation, local heat, noticeable changes in urination or bowl activity or any other complaint)
Change in ejaculation latency time Procedure day The difference between patient ejaculation latency time under perineal functional electrical stimulation during self-stimulation, and latency time during self-stimulation while no electrical stimulation is applied
- Secondary Outcome Measures
Name Time Method Incidence of post-treatment Adverse Events 72 hours Post treatment safety evaluation completed by subjects (using safety questionnaire)
Trial Locations
- Locations (1)
Rambam Health Care Campus
🇮🇱Haifa, Israel